top of page
Certara

Certara

Pipeline
Therapeutic Areas

While the growth of GPTs is incredibly promising, the life sciences industry continues to face challenges with nearly 73% of companies struggling to adopt appropriate AI technologies. This scenario largely comes down to three issues – data security, lack of referencing/transparency and the prevelance of AI hallucinations. Certara.AI deploys a novel GPT architecture that solves these issues, allowing life science companies to access a secure generative AI model with no data leakage, enable AI referencing for improved transparency of data and outputs and lastly a data connectivity framework allowing the generative AI model to operate against the most up-to-date information connected by the user. This allows for specialized AI environments that can be trusted within life sciences and used across a number of use cases including early discovery, biosimulation and medical writing.


AI-Enabled Services:

  • Research services that use large language models (LLM)

  • Research services that use natural language processing (NLP)

  • Data services that use ML, LLMs or NLP

Utilize Certara AI technologies in the following spaces:

  • Chemistry, including analytical chemistry, manufacturing and medicinal chemistry

  • Data, including data transfer, analysis and storage

  • Pharmacology, including in vitro and in vivo disease models

  • Safety, including cardiovascular, pulmonary, neuro and reproductive toxicology


bottom of page